BRAFTOVI

Welcome to the Brand page for “BRAFTOVI”, which is offered here for In the statement lines 4 through 18 is deleted; line 19 ophthalmological use, prevention and, and is deleted, lines 20, 21, and 22 is deleted.;[ anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations for the treatment of heart rhythm disorders; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations for the treatment of kidney diseases; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for treating hypertension; pharmaceutical preparations for treating skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; ] pharmaceutical products for the [ prevention and ] treatment of cancer [ and tumors; pharmaceutical products for the treatment of bone diseases; pharmaceutical products for treating respiratory diseases; pharmaceutical products for treating respiratory diseases and asthma ];.

Its status is currently believed to be active. Its class is unavailable. “BRAFTOVI” is believed to be currently owned by “Array BioPharma Inc.”

Owner:
ARRAY BIOPHARMA INC.
Owner Details
Description:
In the statement lines 4 through 18 is deleted; line 19 ophthalmological use, prevention and, and is deleted, lines 20, 21, and 22 is deleted.;[ Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations for the treatment of heart rhythm disorders; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations for the treatment of kidney diseases; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for treating hypertension; pharmaceutical preparations for treating skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; ] Pharmaceutical products for the [ prevention and ] treatment of cancer [ and tumors; pharmaceutical products for the treatment of bone diseases; pharmaceutical products for treating respiratory diseases; pharmaceutical products for treating respiratory diseases and asthma ];
Categories: STATEMENT LINES